Swimmer Rylee Sayer's philosophy is 'life can pass you by if you let it' - and she's not letting a major amputation limit her ...

Everolimus TFOS is a kinase inhibitor indicated in adult and pediatric patients aged one year and older with tuberous ...

Tim Orth Memorial Foundation basketball jamboree is 4 p.m. Saturday at Glencoe-Silver Lake High School in Glencoe, and as usual all proceeds from that night will go to help kids ...

The Grafton boy has been diagnosed with tuberous sclerosis complex, a rare genetic disease, which he'll have to monitor for ...

A partnership between Aurora Health Care and the Milwaukee Brewers bring three kids' baseball dreams to life. Pediatric ...

Natco Pharma receives FDA approval for Everolimus tablets, launching generic version of Afinitor Disperz in U.S. market.

NATCO Pharma said that it has received approval of its ANDA for Everolimus tablets for oral suspension (TFOS), a generic version of AFINITOR DISPERZ by Novartis Pharmaceutical Corporation.

Natco Pharma has received US FDA approval for its generic version of Everolimus tablets for oral suspension, indicated for ...

Hyderabad: NATCO Pharma Limited, an Indian pharmaceutical company, has announced the approval of its Abbreviated New Drug ...

Natco Pharma Ltd on Thursday said it has received approval from the US health regulator for its generic version of Everolimus ...

Natco Pharma announced approval of its ANDA for Everolimus tablets for oral suspension (TFOS), 2mg, 3mg and 5mg, a generic version of AFINITOR DISPERZ by Novartis Pharmaceutical Corporation. NATCO's ...

Fintel reports that on January 29, 2025, Oppenheimer upgraded their outlook for Ovid Therapeutics (NasdaqGS:OVID) from ...